Interferon regulatory factor 1 is involved in many autoimmune conditions and is increased in patients with myasthenia gravis.However,its function in myasthenia gravis remains unclear.Herein,we explored the function of...Interferon regulatory factor 1 is involved in many autoimmune conditions and is increased in patients with myasthenia gravis.However,its function in myasthenia gravis remains unclear.Herein,we explored the function of interferon regulatory factor 1 in myasthenia gravis,with an aim to understand the underlying mechanisms.Patients with myasthenia gravis who had acetylcholine receptor antibodies were included in the study.Peripheral blood lymphocytes were extracted from the included patients,and B lymphocyte subsets were isolated.Next,T and B cells from peripheral blood were co-cultured to explore the interferon regulatory factor 1-related mechanisms in myasthenia gravis.Chromatin immunoprecipitation experiments confirmed an interaction between interferon regulatory factor 1 and the CD180 promoter region.Dual-luciferase reporter gene confirmed the transcriptional activity of interferon regulatory factor 1 on CD180 promoter.In vitro results further indicated that interferon regulatory factor 1 promoted B cell activation and T cell differentiation via the inhibition of CD180.Interferon regulatory factor 1 recruited histone deacetylase 1 to inhibit CD180 transcription.Additionally,histone deacetylase 1 promoted B cell activation and T cell differentiation.Finally,in vitro experiments demonstrated that CD180 inhibited B cell activation and T cell differentiation by inhibiting the Toll-like receptor 4/mitogen-activated protein kinasesuclear factor-kappa B pathway.Collectively,our results suggest that interferon regulatory factor 1 enhances T cell differentiation by recruiting histone deacetylase 1 to block B cell CD180 transcription in myasthenia gravis via the Toll-like receptor 4/mitogen-activated protein kinasesuclear factor-kappa B pathway.Together,these findings indicate the important role of interferon regulatory factor 1 in myasthenia gravis and suggest its molecular mechanisms.They also provide new ideas and targets for diagnosing and treating myasthenia gravis,which will be both scientifically and clinically valuable.展开更多
Three-dimensional(3D)-printed hydrogel scaffolds are widely used in spinal cord injury repair,with gelatin methacrylate being particularly favored owing to its excellent biocompatibility.However,traditional scaffolds ...Three-dimensional(3D)-printed hydrogel scaffolds are widely used in spinal cord injury repair,with gelatin methacrylate being particularly favored owing to its excellent biocompatibility.However,traditional scaffolds have a small contact area with tissues and lack the ability to regulate the inflammatory microenvironment.Therefore,there is a need to develop smart scaffolds with drug delivery and immune regulation functions.In this study,a 3D-printed gelatin methacrylate scaffold was developed to deliver interferon regulatory factor 4 in a targeted and sustained manner.The scaffold showed good mechanical properties,biocompatibility,and sustained interferon regulatory factor 4 release.The sustained-release interferon regulatory factor 4 competitively bound to myeloid differentiation factor 88 to inhibit the pro-inflammatory effects of interferon regulatory factor 5,and activated the signal transducer and activator of transcription 6 pathway to promote M2 macrophage polarization,thereby facilitating neural regeneration and recovery of spinal cord function.This indicates that the constructed interferon regulatory factor 4-loaded 3D-printed methyl acrylate-modified gelatin scaffold can regulate macrophage polarization through the interferon regulatory factor 4/5 axis,improve the inflammatory microenvironment after spinal cord injury,and thus provide a new target for promoting neural regeneration.展开更多
BACKGROUND Chronic hepatitis B(CHB)is a significant global health issue,and interferon(IFN)is one of the main first-line therapies for CHB.AIM To investigate the altered transcriptome,metabolites,and their correlation...BACKGROUND Chronic hepatitis B(CHB)is a significant global health issue,and interferon(IFN)is one of the main first-line therapies for CHB.AIM To investigate the altered transcriptome,metabolites,and their correlations,as well as the effects and mechanisms of IFN treatment for CHB.METHODS The patients received peginterferon alfa-2b at a dose of 180μg for 0,1,3,and 6 months and serum samples were collected for clinical biological assays,transcriptomics,and metabolomics analyses.RESULTS The results showed that IFN-related immune pathways and neutrophil extracellular traps(NETs)were the most significantly altered pathways following IFN treatment.Correlation analysis revealed a strong link between immune system-related genes in the transcriptome and dipeptides in the metabolome during IFN-αtreatment.Notably,core components of NETs,including histones H2A clustered histone 14,H2B clustered histone 5,H3 clustered histone 1,and H4 clustered histone 4,were significantly increased after IFN treatment.The positively charged histones may bind to the negatively charged viral envelope,potentially enhancing the antiviral effect.CONCLUSION Integrated non-targeted transcriptomic and metabolomic analyses to CHB patients undergoing IFN-αtreatment revealed that IFN-related immune pathways and NETs were the most significantly affected pathways during IFN treatment.These findings provide a deeper understanding of the role of NETs and dipeptides in the antiviral response to IFN treatment for CHB.展开更多
BACKGROUND Chronic hepatitis B(CHB)is a major global health burden,with China being the most affected.Achieving a clinical cure,defined as hepatitis B surface antigen(HBsAg)clearance,is the ideal treatment endpoint.Wh...BACKGROUND Chronic hepatitis B(CHB)is a major global health burden,with China being the most affected.Achieving a clinical cure,defined as hepatitis B surface antigen(HBsAg)clearance,is the ideal treatment endpoint.While a 48-week interferon course is standard,extended therapy may improve HBsAg clearance rates.However,there exists a notable gap in predictive modeling studies concerning extended treatment courses(≥48 weeks).AIM To develop a predictive model for identifying patients who require extended interferon therapy(≥48 weeks)for HBsAg clearance.METHODS This multicenter retrospective study included CHB patients,including those with compensated cirrhosis,who achieved HBsAg clearance(HBsAg<0.05 IU/mL)following treatment with pegylated interferon alpha-2b,either alone or in combination with nucleoside analogs.After propensity score matching,we employed least absolute shrinkage and selection operator(LASSO)regression and multivariate regression to identify independent predictors.RESULTS A total of 688 eligible patients with CHB were enrolled in this study.After propensity score matching at a 1:1 ratio,375 patients remained,including 196 in the training cohort.Among the training cohort,36(18.37%)were classified in the extended course(≥48 weeks)and 160(81.63%)in the regular course(<48 weeks).LASSO and multivariate regression analyses identified baseline HBsAg and cirrhosis as significant risk factors for extended interferon therapy.The model demonstrated strong discriminatory ability,with the area under the curve of 0.83[95%confidence interval(CI):0.76-0.91]for the training cohort and 0.81(95%CI:0.71-0.90)for the externally validated cohort.The model’s predictive efficacy was not influenced by subgroup characteristics.CONCLUSION This study successfully constructed and validated a prediction model based on baseline HBsAg and cirrhosis to identify potential populations that may benefit from extended interferon therapy(≥48 weeks).展开更多
The type I interferon(IFN-I)system serves as a frontline defense against viral infection,yet how orthobunyaviruses counteract this pathway remains poorly defined.Here,we identify cytochrome P4501A1(CYP1A1)as a crucial...The type I interferon(IFN-I)system serves as a frontline defense against viral infection,yet how orthobunyaviruses counteract this pathway remains poorly defined.Here,we identify cytochrome P4501A1(CYP1A1)as a crucial host factor promoting infection by two emerging orthobunyaviruses-Oya virus(OYAV)and Ebinur Lake virus(EBIV).Transcriptomic and functional analyses demonstrate that CYP1A1 overexpression enhances viral RNA synthesis,whereas its CRISPR-Cas9mediated knockout attenuates infection.Mechanistically,OYAV and EBIV activate the aryl hydrocarbon receptor(AhR),driving its nuclear translocation and subsequent upregulation of CYP1A1.Deficiency of CYP1A1 potentiates IFN-βproduction and interferon-stimulated gene(ISG)expression,while its overexpression suppressed antiviral signaling,revealing an immunomodulatory role that is distinct from its canonical metabolic function.Collectively,this work defines the AhR-CYP1A1 axis as a conserved immune-evasion module exploited by emerging orthobunyaviruses and highlights the innate immune pathway as a potential therapeutic target against these emerging threats.展开更多
BACKGROUND Chronic hepatitis B(CHB)remains a critical global health challenge,with few patients achieving spontaneous clearance of hepatitis B surface antigen(HBsAg),which is a key indicator of functional cure.T cell ...BACKGROUND Chronic hepatitis B(CHB)remains a critical global health challenge,with few patients achieving spontaneous clearance of hepatitis B surface antigen(HBsAg),which is a key indicator of functional cure.T cell plays an important role in HBsAg clearance.AIM To compare T cell receptor(TCR)fingerprints between patients with or without HBsAg clearance after pegylated interferon alpha-2b(PegIFNα-2b)added on nucleos(t)ide analogues(NAs).METHODS In this observational study,peripheral blood mononuclear cells(PBMCs)were isolated from six comparable CHB patients who achieved HBsAg clearance(Group-C)or not(Group-NC)after 48 weeks of PegIFNα-2b added to NA therapy.Patients in Group-C and Group-NC had comparable age,gender,baseline hepatitis B virus(HBV)DNA,HBsAg,hepatitis B envelop antigen(HBeAg),total bilirubin,alanine aminotransferase(ALT)and cirrhosis status.All patients had received at least one year of NA before PegIFNα-2b therapy.TCR repertoire profiles(fingerprints)were screened and compared by RNA sequencing and bioinformation analysis between the two groups.RESULTS Six male patients without cirrhosis were enrolled in this study,with three patients in each group.200 ng of RNA from each PBMC sample was extracted for standard RNA sequencing for construction of a complementary DNA library.Baseline levels of HBsAg,HBeAg,HBV DNA(0.05).It was found that compared to Group-NC,Group-C had significantly higher TCR diversity in bothαandβchain,including more unique clonotypes(P=0.017,P=0.038 respectively),more repertoire overlap(P=0.002,P=0.002 respectively),a broader complementarity-determining region3 length distribution,and higher Chao1 index(P=0.016,P=0.048 respectively).CONCLUSION Patients with HBsAg clearance had a more diverse and robust T cell response,which may correlate with HBsAg clearance status.These immune signatures may serve as potential reference indicators for PegIFNα-2b treatment response in CHB patients.展开更多
Interferon regulatory factor 7 plays a crucial role in the innate immune response.However,whether interferon regulatory factor 7-mediated signaling contributes to Parkinson's disease remains unknown.Here we report...Interferon regulatory factor 7 plays a crucial role in the innate immune response.However,whether interferon regulatory factor 7-mediated signaling contributes to Parkinson's disease remains unknown.Here we report that interferon regulatory factor 7 is markedly up-regulated in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease and co-localizes with microglial cells.Both the selective cyclic guanosine monophosphate adenosine monophosphate synthase inhibitor RU.521 and the stimulator of interferon genes inhibitor H151 effectively suppressed interferon regulatory factor 7 activation in BV2 microglia exposed to 1-methyl-4-phenylpyridinium and inhibited transformation of mouse BV2 microglia into the neurotoxic M1 phenotype.In addition,si RNA-mediated knockdown of interferon regulatory factor 7 expression in BV2 microglia reduced the expression of inducible nitric oxide synthase,tumor necrosis factorα,CD16,CD32,and CD86 and increased the expression of the anti-inflammatory markers ARG1 and YM1.Taken together,our findings indicate that the cyclic guanosine monophosphate adenosine monophosphate synthase-stimulator of interferon genes-interferon regulatory factor 7 pathway plays a crucial role in the pathogenesis of Parkinson's disease.展开更多
BACKGROUND Chronic hepatitis B(CHB)patients rarely achieve functional cure with initial pegylated interferon alpha-2b(Peg-IFNα-2b)therapy.Validated tools to guide retreatment candidates are lacking.We hypothesized th...BACKGROUND Chronic hepatitis B(CHB)patients rarely achieve functional cure with initial pegylated interferon alpha-2b(Peg-IFNα-2b)therapy.Validated tools to guide retreatment candidates are lacking.We hypothesized that clinical indicators predict hepatitis B surface antigen(HBsAg)clearance during retreatment.AIM To develop a prediction model for HBsAg clearance in Peg-IFNα-2b retreatment.METHODS In this retrospective cohort study,we enrolled 135 CHB/compensated cirrhosis patients receiving Peg-IFNα-2b retreatment after initial non-clearance at Tianjin University Central Hospital(2017-2025).Predictors were identified through univariate Cox,least absolute shrinkage and selection operator,and multivariate Cox regression.Model performance was assessed via receiver operating characteristic analysis and Harrell’s C-index,with risk stratification by X-tile optimization.RESULTS HBsAg clearance rate was 20.74%(28/135).Independent predictors included:Combination nucleos(t)ide analogue(NA)therapy during initial treatment[hazard ratio(HR)=0.276,95%confidence interval(CI):0.092-0.833],baseline HBsAg at retreatment(HR=0.571,95%CI:0.410-0.795),HBsAg decline after initial treatment(HR=2.050,95%CI:1.108-3.793),and treatment interval(HR=1.013/week,95%CI:1.008-1.018).The retreatment HBsAg clearance prediction score(RHCP-S)demonstrated area under the curve of 0.920(95%CI:0.863-0.946),sensitivity of 92.3%,specificity of 79.3%.Clearance rates differed significantly:RHCP-S challenge group(≤74 points):3.45%,RHCP-S probable group(74-110 points):29.63%,RHCP-S dominant group(≥110 points):80.95%(P<0.001).CONCLUSION The overall HBsAg clearance rate with Peg-IFNα-2b retreatment was 20.74%(28/135).The RHCP-S model identifies optimal retreatment candidates(≥110 points)with 80.95%clearance probability,associated with the absence of combination NA therapy during initial treatment,greater initial HBsAg decline,longer intervals,and lower retreatment HBsAg.展开更多
BACKGROUND Hepatocellular carcinoma(HCC)ranks as the fourth leading cause of cancerrelated deaths in China,and the treatment options are limited.The cyclic guanosine monophosphate-adenosine monophosphate synthase(cGAS...BACKGROUND Hepatocellular carcinoma(HCC)ranks as the fourth leading cause of cancerrelated deaths in China,and the treatment options are limited.The cyclic guanosine monophosphate-adenosine monophosphate synthase(cGAS)activates the stimulator of interferon gene(STING)signaling pathway as a crucial immune response pathway in the cytoplasm,which detects cytoplasmic DNA to regulate innate and adaptive immune responses.As a potential therapeutic target,cGASSTING pathway markedly inhibits tumor cell proliferation and metastasis,with its activation being particularly relevant in HCC.However,prolonged pathway activation may lead to an immunosuppressive tumor microenvironment,which fostering the invasion or metastasis of liver tumor cells.AIM To investigate the dual-regulation mechanism of cGAS-STING in HCC.METHODS This review was conducted according to the PRISMA guidelines.The study conducted a comprehensive search for articles related to HCC on PubMed and Web of Science databases.Through rigorous screening and meticulous analysis of the retrieved literature,the research aimed to summarize and elucidate the impact of the cGAS-STING pathway on HCC tumors.RESULTS All authors collaboratively selected studies for inclusion,extracted data,and the initial search of online databases yielded 1445 studies.After removing duplicates,remaining 964 records were screened.Ultimately,55 articles met the inclusion criteria and were included in this review.CONCLUSION Acute inflammation can have a few inhibitory effects on cancer,while chronic inflammation generally promotes its progression.Extended cGAS-STING pathway activation will result in a suppressive tumor microenvironment.展开更多
The cyclic GMP-AMP synthase(cGAS)-stimulator of interferon genes(STING)signaling pathway has emerged as a key mediator of neuroinflammation.While current studies primarily attribute its effects to neurons and glial ce...The cyclic GMP-AMP synthase(cGAS)-stimulator of interferon genes(STING)signaling pathway has emerged as a key mediator of neuroinflammation.While current studies primarily attribute its effects to neurons and glial cells,emerging research suggests that cGAS-STING signaling may play a critical role in cerebral vasculature,particularly in brain endothelial cells.Therefore,studying the role 7of inflammation caused by the cGAS-STING pathway in brain endothelial cells could provide a more comprehensive understanding of neuroinflammatory disease and new avenues for therapeutic interventions.Here,we review the multifaceted role of global cGAS-STING signaling in various neurological and neuroinflammatory diseases and the potential contribution of cGAS-STING in brain endothelial cells.展开更多
AIM:To investigate the expression of interferon regulatory factors(IRFs)in peripheral blood mononuclear cells(PBMCs)of patients with Sjögren’s syndrome-related dry eye(SSDE)and to explore their correlation with ...AIM:To investigate the expression of interferon regulatory factors(IRFs)in peripheral blood mononuclear cells(PBMCs)of patients with Sjögren’s syndrome-related dry eye(SSDE)and to explore their correlation with clinical features,dendritic cell activation,and serological indicators.METHODS:A total of 53 SSDE patients and 62 non-Sjögren’s syndrome dry eye(NSSDE)patients were enrolled.Demographic and clinical data were collected,and comprehensive ophthalmic examinations were performed,including the ocular surface disease index(OSDI)questionnaires,Schirmer I test(SIT),tear break-up time(TBUT),corneal fluorescein staining score(CFS),and in vivo confocal microscopy(IVCM).PBMCs were isolated,and IRFs expression levels were analyzed using Western blotting(WB)and quantitative real-time polymerase chain reaction(qRT-PCR).Serological indicators,including antinuclear antibodies(ANA)and anti-Ro60,anti-Ro52,and anti-La autoantibodies,were detected.Statistical analyses evaluated correlations between IRFs expression and clinical parameters.RESULTS:Compared to NSSDE,the relative mRNA and protein expression of the IRF-8 was significantly upregulated in patients with SSDE(P<0.001),whereas no significant differences were observed in IRF-1,IRF-3,IRF-5,and IRF-7(P=0.12,P=0.10,P=0.66,P=0.96).Correlation analysis revealed that IRF-8 expression was positively associated with CFS and OSDI scores(r=0.57,r=0.38,both P<0.05).Moreover,IRF-8 expression correlated with corneal dendritic cell(DC)density and size,and the number of dendrites(r=0.43,r=0.40,r=0.65,all P<0.05).IRF-8 expression was significantly elevated in patients positive for anti-Ro60,anti-Ro52 and anti-La autoantibodies(P<0.05).CONCLUSION:In SSDE,IRF-8 is upregulated and associated with clinical features,DC activation,and serological indicators.These findings suggest that IRF-8 plays a critical role in SSDE pathogenesis and may serve as a potential therapeutic target for diagnosis and treatment.展开更多
OBJECTIVE:To examine the effects of the Jianpi Yifei Tongluo recipe(健脾益肺通络方剂,JYTR)on chronic obstructive pulmonary disease(COPD)within an animal model and to elucidate its anti-inflammatory mechanisms.METHODS:...OBJECTIVE:To examine the effects of the Jianpi Yifei Tongluo recipe(健脾益肺通络方剂,JYTR)on chronic obstructive pulmonary disease(COPD)within an animal model and to elucidate its anti-inflammatory mechanisms.METHODS:In this study,we utilized cigarette smoke(CS)exposure and lipopolysaccharide(LPS)-induced models of COPD in rats to evaluate the effects of the JYTR on airway inflammation.Sprague-Dawley rats were randomly assigned to various groups:control,model,budesonide,synbiotics,and low,medium,and high JYTR.Pulmonary function was gauged using an animal volumetric tracer.Pathological alterations in lung tissue were examined under a light microscope.To ascertain cytokine production,we conducted enzyme-linked immunosorbent assay tests,and we employed Western blotting to measure the expression levels of interferon regulatory factor 4(IRF4),arginase 1(Arg1),inducible nitric oxide synthase(iNOS),nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor,alpha(IKB-α),and P65.RESULTS:Compared to the control group,rats in the COPD model group exhibited significantly compromised pulmonary function and severe inflammatory pathology in the lungs.Treatment with budesonide,synbiotics,and the JYTR markedly improved pulmonary function and diminished the production of inflammatory cytokines transforming growth factor-beta(TGF-β),tumor necrosis factor-alpha(TNF-α),and interleukin-6(IL-6).These improvements were particularly notable in the budesonide group and the high-dose JYTR group.Additionally,the JYTR increased the expression of IRF4 and upregulated the protein expression of Arg1,while concurrently downregulating the protein expression of iNOS,phosphorylated IKB-α,and phosphorylated P65.CONCLUSION:Our current study reveals that JYTR can mitigate inflammatory lung injury,enhance lung function,and lower levels of inflammatory cytokines induced by CS or LPS exposure in COPD model rats.The mechanism behind its anti-inflammatory effect likely involves the regulation of IRF4 expression and M2 polarization through the nuclear factor kappa-light-chain-enhancer of activated B cells signaling pathway.展开更多
The canonical signaling of interferon gamma(IFN-γ)through the Janus kinase 1 and 2–signal transducer and activator of transcription 1(STAT1)axis leads to the expression of several interferon-stimulated genes(ISGs),w...The canonical signaling of interferon gamma(IFN-γ)through the Janus kinase 1 and 2–signal transducer and activator of transcription 1(STAT1)axis leads to the expression of several interferon-stimulated genes(ISGs),which have diverse effects depending on the cellular context.In glioblastoma,a highly aggressive primary brain tumor in adults,elements of IFN-γcanonical signaling are deregulated,resulting in the overexpression of STAT1-target ISGs associated with tumor progression.This mini-review highlights key ISGs,including STAT1,interferon regulatory factor 1,programmed death-ligand 1,indoleamine 2,3-dioxygenase 1,and interferon-stimulated gene 15,involved in the pathology of glioblastoma.These genes may serve as valuable biomarkers and have therapeutic potential for targeting IFN-γsignaling in this malignancy.展开更多
The reconstruction of neural function and recovery of chronic damage following traumatic brain injury(TBI)remain significant clinical challenges.Exosomes derived from neural stem cells(NSCs)offer various benefits inTB...The reconstruction of neural function and recovery of chronic damage following traumatic brain injury(TBI)remain significant clinical challenges.Exosomes derived from neural stem cells(NSCs)offer various benefits inTBI treatment.Numerous studies confirmed that appropriate preconditioning methods enhanced the targetedefficacy of exosome therapy.Interferon-gamma(IFN-γ)possesses immunomodulatory capabilities and is widelyinvolved in neurological disorders.In this study,IFN-γwas employed for preconditioning NSCs to enhance theefficacy of exosome(IFN-Exo,IE)for TBI.miRNA sequencing revealed the potential of IFN-Exo in promotingneural differentiation and modulating inflammatory responses.Through low-temperature 3D printing,IFN-Exowas combined with collagen/chitosan(3D-CC-IE)to preserve the biological activity of the exosome.The deliveryof exosomes via biomaterial scaffolds benefited the retention and therapeutic potential of exosomes,ensuring that they could exert long-term effects at the injury site.The 3D-CC-IE scaffold exhibited excellentbiocompatibility and mechanical properties.Subsequently,3D-CC-IE scaffold significantly improved impairedmotor and cognitive functions after TBI in rat.Histological results showed that 3D-CC-IE scaffold markedlyfacilitated the reconstruction of damaged neural tissue and promoted endogenous neurogenesis.Furthermechanistic validation suggested that IFN-Exo alleviated neuroinflammation by modulating the MAPK/mTORsignaling pathway.In summary,the results of this study indicated that 3D-CC-IE scaffold engaged in long-termpathophysiological processes,fostering neural function recovery after TBI,offering a promising regenerativetherapy avenue.展开更多
Scutellariae Radix(SR)is widely used in Chinese medicine for influenza treatment;however,the mechanisms underlying its effect remain unknown.Here,we report,for the first time,that the therapeutic effects of SR on infl...Scutellariae Radix(SR)is widely used in Chinese medicine for influenza treatment;however,the mechanisms underlying its effect remain unknown.Here,we report,for the first time,that the therapeutic effects of SR on influenza involve regulation of antiviral interferons(IFNs),typeⅠand typeⅢIFNs(IFN-Is and IFN-Ⅲs,respectively),particularly through the modulation of IFN-I production and its downstream effects in a cell type-specific manner.SR treatment resulted in symptomatic improvement in A/Puerto Rico/8/34(H1N1)virus(PR8)-infected mice.It exhibited direct antiviral activity in the early stages of virus infection in A/WSN/33(H1N1)(WSN)-infected Madin-Darby canine kidney(MDCK)cells.Next,we investigated the effects of SR on the upstream antiviral IFN pathways and downstream effects in human lung adenocarcinoma(A549)cells,human monocytic leukemia(THP-1)cells,and neutrophils(Neu).SR exhibited dual regulatory roles,enhancing the production and activity of antiviral IFNs via the nuclear factor-kappaB(NF-κB)/IFN regulatory factor 3(IRF3)and Janus kinase/signal transducer and activator of transcription(JAK/STAT)signaling pathways.It also reduced IFN-I-induced neutrophil inflammation by inhibiting reactive oxygen species(ROS)and neutrophil extracellular trap(NET)production,and alleviated inflammation in A549 and THP-1 cells via NF-κB/cFOS or mitogen-activated protein kinase(MAPK)/c-Jun signaling.Subsequently,the importance of IFN-Ⅰ/IFN-Ⅲwas verified using IFN alpha receptor 1(Ifnar1)-/-and IFN lambda receptor 1(Ifnlr1)-/-mice.The absence of IFNAR or IFNLR significantly diminished the therapeutic effect of SR against influenza,highlighting its dependence on the IFN-Ⅰ/IFN-Ⅲsystems.Finally,a delayed drug administration experiment in PR8-infected mice revealed that the therapeutic effect of SR heavily relies on early induction of IFN.Overall,our findings offer valuable insights for the clinical utilization of SR,as well as for further exploration of antiviral treatments.展开更多
Interferon-related genes are involved in antiviral responses,inflammation,and immunity,which are closely related to sepsis-associated acute respiratory distress syndrome(ARDS).We analyzed 1972 participants with genoty...Interferon-related genes are involved in antiviral responses,inflammation,and immunity,which are closely related to sepsis-associated acute respiratory distress syndrome(ARDS).We analyzed 1972 participants with genotype data and 681 participants with gene expression data from the Molecular Epidemiology of ARDS(MEARDS),the Molecular Epidemiology of Sepsis in the ICU(MESSI),and the Molecular Diagnosis and Risk Stratification of Sepsis(MARS)cohorts in a three-step study focusing on sepsis-associated ARDS and sepsis-only controls.First,we identified and validated interferon-related genes associated with sepsis-associated ARDS risk using genetically regulated gene expression(GReX).Second,we examined the association of the confirmed gene(interferon regulatory factor 1,IRF1)with ARDS risk and survival and conducted a mediation analysis.Through discovery and validation,we found that the GReX of IRF1 was associated with ARDS risk(odds ratio[ORMEARDS]=0.84,P=0.008;ORMESSI=0.83,P=0.034).Furthermore,individual-level measured IRF1 expression was associated with reduced ARDS risk(OR=0.58,P=8.67×10-4),and improved overall survival in ARDS patients(hazard ratio[HR28-day]=0.49,P=0.009)and sepsis patients(HR28-day=0.76,P=0.008).Mediation analysis revealed that IRF1 may enhance immune function by regulating the major histocompatibility complex,including HLA-F,which mediated more than 70%of protective effects of IRF1 on ARDS.The findings were validated by in vitro biological experiments including time-series infection dynamics,overexpression,knockout,and chromatin immunoprecipitation sequencing.Early prophylactic interventions to activate IRF1 in sepsis patients,thereby regulating HLA-F,may reduce the risk of ARDS and mortality,especially in severely ill patients.展开更多
1|From STING Promise to Translational Challenges The cyclic GMP‐AMP synthase‐stimulator of interferon genes(cGAS‐STING)pathway has emerged as a central innate immune‐sensing axis and a promising target for cancer ...1|From STING Promise to Translational Challenges The cyclic GMP‐AMP synthase‐stimulator of interferon genes(cGAS‐STING)pathway has emerged as a central innate immune‐sensing axis and a promising target for cancer immunotherapy[1-3].Upon sensing cytosolic DNA derived from pathogens,damaged cells,or tumor cells,cGAS catalyzes the production of cyclic dinucleotides(CDNs),which subsequently bind to STING and activate downstream IRF3 and NF‐κB signaling pathways[1,2].This process induces type I interferons and proinflammatory cytokines,thereby linking innate immune activation with adaptive antitumor immunity[3,4].The ability of STING signaling to activate dendritic cells,promote antigen presentation,and stimulate cytotoxic T‐cell responses has made STING agonists attractive candidates for cancer therapy[4,5].Nevertheless,clinical translation has remained difficult.CDN‐based STING agonists usually suffer from rapid enzymatic degradation,poor membrane permeability,short circulation half‐lives,and inefficient tumor accumulation after systemic administration.As a result,many early‐generation STING agonists have relied on intratumoral injection,restricting their use to accessible lesions and limiting their impact on metastatic disease[6].展开更多
基金National Natural Science Foundation of China,No.82271440Jiangxi Provincial Health Technology Project,No.202510009(both to LX).
摘要Interferon regulatory factor 1 is involved in many autoimmune conditions and is increased in patients with myasthenia gravis.However,its function in myasthenia gravis remains unclear.Herein,we explored the function of interferon regulatory factor 1 in myasthenia gravis,with an aim to understand the underlying mechanisms.Patients with myasthenia gravis who had acetylcholine receptor antibodies were included in the study.Peripheral blood lymphocytes were extracted from the included patients,and B lymphocyte subsets were isolated.Next,T and B cells from peripheral blood were co-cultured to explore the interferon regulatory factor 1-related mechanisms in myasthenia gravis.Chromatin immunoprecipitation experiments confirmed an interaction between interferon regulatory factor 1 and the CD180 promoter region.Dual-luciferase reporter gene confirmed the transcriptional activity of interferon regulatory factor 1 on CD180 promoter.In vitro results further indicated that interferon regulatory factor 1 promoted B cell activation and T cell differentiation via the inhibition of CD180.Interferon regulatory factor 1 recruited histone deacetylase 1 to inhibit CD180 transcription.Additionally,histone deacetylase 1 promoted B cell activation and T cell differentiation.Finally,in vitro experiments demonstrated that CD180 inhibited B cell activation and T cell differentiation by inhibiting the Toll-like receptor 4/mitogen-activated protein kinasesuclear factor-kappa B pathway.Collectively,our results suggest that interferon regulatory factor 1 enhances T cell differentiation by recruiting histone deacetylase 1 to block B cell CD180 transcription in myasthenia gravis via the Toll-like receptor 4/mitogen-activated protein kinasesuclear factor-kappa B pathway.Together,these findings indicate the important role of interferon regulatory factor 1 in myasthenia gravis and suggest its molecular mechanisms.They also provide new ideas and targets for diagnosing and treating myasthenia gravis,which will be both scientifically and clinically valuable.
基金supported by the National Natural Science Foundation of China,Nos.81930070(to SF),82002309(to ZS)the Tianjin Key Medical Discipline(Specialty)Construct Project,No.TJYXZDXK-027A(to SF)a grant from Tianjin Institute of Orthopedic Innovation and Transformation(to SF).
摘要Three-dimensional(3D)-printed hydrogel scaffolds are widely used in spinal cord injury repair,with gelatin methacrylate being particularly favored owing to its excellent biocompatibility.However,traditional scaffolds have a small contact area with tissues and lack the ability to regulate the inflammatory microenvironment.Therefore,there is a need to develop smart scaffolds with drug delivery and immune regulation functions.In this study,a 3D-printed gelatin methacrylate scaffold was developed to deliver interferon regulatory factor 4 in a targeted and sustained manner.The scaffold showed good mechanical properties,biocompatibility,and sustained interferon regulatory factor 4 release.The sustained-release interferon regulatory factor 4 competitively bound to myeloid differentiation factor 88 to inhibit the pro-inflammatory effects of interferon regulatory factor 5,and activated the signal transducer and activator of transcription 6 pathway to promote M2 macrophage polarization,thereby facilitating neural regeneration and recovery of spinal cord function.This indicates that the constructed interferon regulatory factor 4-loaded 3D-printed methyl acrylate-modified gelatin scaffold can regulate macrophage polarization through the interferon regulatory factor 4/5 axis,improve the inflammatory microenvironment after spinal cord injury,and thus provide a new target for promoting neural regeneration.
摘要BACKGROUND Chronic hepatitis B(CHB)is a significant global health issue,and interferon(IFN)is one of the main first-line therapies for CHB.AIM To investigate the altered transcriptome,metabolites,and their correlations,as well as the effects and mechanisms of IFN treatment for CHB.METHODS The patients received peginterferon alfa-2b at a dose of 180μg for 0,1,3,and 6 months and serum samples were collected for clinical biological assays,transcriptomics,and metabolomics analyses.RESULTS The results showed that IFN-related immune pathways and neutrophil extracellular traps(NETs)were the most significantly altered pathways following IFN treatment.Correlation analysis revealed a strong link between immune system-related genes in the transcriptome and dipeptides in the metabolome during IFN-αtreatment.Notably,core components of NETs,including histones H2A clustered histone 14,H2B clustered histone 5,H3 clustered histone 1,and H4 clustered histone 4,were significantly increased after IFN treatment.The positively charged histones may bind to the negatively charged viral envelope,potentially enhancing the antiviral effect.CONCLUSION Integrated non-targeted transcriptomic and metabolomic analyses to CHB patients undergoing IFN-αtreatment revealed that IFN-related immune pathways and NETs were the most significantly affected pathways during IFN treatment.These findings provide a deeper understanding of the role of NETs and dipeptides in the antiviral response to IFN treatment for CHB.
基金Supported by the Tianjin Health Research Project(Key Project),No.TJWJ2024ZD004.
摘要BACKGROUND Chronic hepatitis B(CHB)is a major global health burden,with China being the most affected.Achieving a clinical cure,defined as hepatitis B surface antigen(HBsAg)clearance,is the ideal treatment endpoint.While a 48-week interferon course is standard,extended therapy may improve HBsAg clearance rates.However,there exists a notable gap in predictive modeling studies concerning extended treatment courses(≥48 weeks).AIM To develop a predictive model for identifying patients who require extended interferon therapy(≥48 weeks)for HBsAg clearance.METHODS This multicenter retrospective study included CHB patients,including those with compensated cirrhosis,who achieved HBsAg clearance(HBsAg<0.05 IU/mL)following treatment with pegylated interferon alpha-2b,either alone or in combination with nucleoside analogs.After propensity score matching,we employed least absolute shrinkage and selection operator(LASSO)regression and multivariate regression to identify independent predictors.RESULTS A total of 688 eligible patients with CHB were enrolled in this study.After propensity score matching at a 1:1 ratio,375 patients remained,including 196 in the training cohort.Among the training cohort,36(18.37%)were classified in the extended course(≥48 weeks)and 160(81.63%)in the regular course(<48 weeks).LASSO and multivariate regression analyses identified baseline HBsAg and cirrhosis as significant risk factors for extended interferon therapy.The model demonstrated strong discriminatory ability,with the area under the curve of 0.83[95%confidence interval(CI):0.76-0.91]for the training cohort and 0.81(95%CI:0.71-0.90)for the externally validated cohort.The model’s predictive efficacy was not influenced by subgroup characteristics.CONCLUSION This study successfully constructed and validated a prediction model based on baseline HBsAg and cirrhosis to identify potential populations that may benefit from extended interferon therapy(≥48 weeks).
基金supported by the National Key Research and Development Program of China(2023YFC2305900)the Youth Program of Wuhan Institute of Virology(2023QNTJ-03).
摘要The type I interferon(IFN-I)system serves as a frontline defense against viral infection,yet how orthobunyaviruses counteract this pathway remains poorly defined.Here,we identify cytochrome P4501A1(CYP1A1)as a crucial host factor promoting infection by two emerging orthobunyaviruses-Oya virus(OYAV)and Ebinur Lake virus(EBIV).Transcriptomic and functional analyses demonstrate that CYP1A1 overexpression enhances viral RNA synthesis,whereas its CRISPR-Cas9mediated knockout attenuates infection.Mechanistically,OYAV and EBIV activate the aryl hydrocarbon receptor(AhR),driving its nuclear translocation and subsequent upregulation of CYP1A1.Deficiency of CYP1A1 potentiates IFN-βproduction and interferon-stimulated gene(ISG)expression,while its overexpression suppressed antiviral signaling,revealing an immunomodulatory role that is distinct from its canonical metabolic function.Collectively,this work defines the AhR-CYP1A1 axis as a conserved immune-evasion module exploited by emerging orthobunyaviruses and highlights the innate immune pathway as a potential therapeutic target against these emerging threats.
基金Supported by Science Foundation of Jinling Hospital,Affiliated Hospital of Medical School,Nanjing University,No.22JCYYYB11.
摘要BACKGROUND Chronic hepatitis B(CHB)remains a critical global health challenge,with few patients achieving spontaneous clearance of hepatitis B surface antigen(HBsAg),which is a key indicator of functional cure.T cell plays an important role in HBsAg clearance.AIM To compare T cell receptor(TCR)fingerprints between patients with or without HBsAg clearance after pegylated interferon alpha-2b(PegIFNα-2b)added on nucleos(t)ide analogues(NAs).METHODS In this observational study,peripheral blood mononuclear cells(PBMCs)were isolated from six comparable CHB patients who achieved HBsAg clearance(Group-C)or not(Group-NC)after 48 weeks of PegIFNα-2b added to NA therapy.Patients in Group-C and Group-NC had comparable age,gender,baseline hepatitis B virus(HBV)DNA,HBsAg,hepatitis B envelop antigen(HBeAg),total bilirubin,alanine aminotransferase(ALT)and cirrhosis status.All patients had received at least one year of NA before PegIFNα-2b therapy.TCR repertoire profiles(fingerprints)were screened and compared by RNA sequencing and bioinformation analysis between the two groups.RESULTS Six male patients without cirrhosis were enrolled in this study,with three patients in each group.200 ng of RNA from each PBMC sample was extracted for standard RNA sequencing for construction of a complementary DNA library.Baseline levels of HBsAg,HBeAg,HBV DNA(0.05).It was found that compared to Group-NC,Group-C had significantly higher TCR diversity in bothαandβchain,including more unique clonotypes(P=0.017,P=0.038 respectively),more repertoire overlap(P=0.002,P=0.002 respectively),a broader complementarity-determining region3 length distribution,and higher Chao1 index(P=0.016,P=0.048 respectively).CONCLUSION Patients with HBsAg clearance had a more diverse and robust T cell response,which may correlate with HBsAg clearance status.These immune signatures may serve as potential reference indicators for PegIFNα-2b treatment response in CHB patients.
基金supported by the National Natural Science Foundation of China,Nos.82171429,81771384a grant from Wuxi Municipal Health Commission,No.1286010241190480(all to YS)。
摘要Interferon regulatory factor 7 plays a crucial role in the innate immune response.However,whether interferon regulatory factor 7-mediated signaling contributes to Parkinson's disease remains unknown.Here we report that interferon regulatory factor 7 is markedly up-regulated in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease and co-localizes with microglial cells.Both the selective cyclic guanosine monophosphate adenosine monophosphate synthase inhibitor RU.521 and the stimulator of interferon genes inhibitor H151 effectively suppressed interferon regulatory factor 7 activation in BV2 microglia exposed to 1-methyl-4-phenylpyridinium and inhibited transformation of mouse BV2 microglia into the neurotoxic M1 phenotype.In addition,si RNA-mediated knockdown of interferon regulatory factor 7 expression in BV2 microglia reduced the expression of inducible nitric oxide synthase,tumor necrosis factorα,CD16,CD32,and CD86 and increased the expression of the anti-inflammatory markers ARG1 and YM1.Taken together,our findings indicate that the cyclic guanosine monophosphate adenosine monophosphate synthase-stimulator of interferon genes-interferon regulatory factor 7 pathway plays a crucial role in the pathogenesis of Parkinson's disease.
基金Supported by the Tianjin Health Research Project(Key Project),No.TJWJ2024ZD004Tianjin Key Medical Discipline(Specialty)Construction Project,No.TJYXZDXK-034A.
摘要BACKGROUND Chronic hepatitis B(CHB)patients rarely achieve functional cure with initial pegylated interferon alpha-2b(Peg-IFNα-2b)therapy.Validated tools to guide retreatment candidates are lacking.We hypothesized that clinical indicators predict hepatitis B surface antigen(HBsAg)clearance during retreatment.AIM To develop a prediction model for HBsAg clearance in Peg-IFNα-2b retreatment.METHODS In this retrospective cohort study,we enrolled 135 CHB/compensated cirrhosis patients receiving Peg-IFNα-2b retreatment after initial non-clearance at Tianjin University Central Hospital(2017-2025).Predictors were identified through univariate Cox,least absolute shrinkage and selection operator,and multivariate Cox regression.Model performance was assessed via receiver operating characteristic analysis and Harrell’s C-index,with risk stratification by X-tile optimization.RESULTS HBsAg clearance rate was 20.74%(28/135).Independent predictors included:Combination nucleos(t)ide analogue(NA)therapy during initial treatment[hazard ratio(HR)=0.276,95%confidence interval(CI):0.092-0.833],baseline HBsAg at retreatment(HR=0.571,95%CI:0.410-0.795),HBsAg decline after initial treatment(HR=2.050,95%CI:1.108-3.793),and treatment interval(HR=1.013/week,95%CI:1.008-1.018).The retreatment HBsAg clearance prediction score(RHCP-S)demonstrated area under the curve of 0.920(95%CI:0.863-0.946),sensitivity of 92.3%,specificity of 79.3%.Clearance rates differed significantly:RHCP-S challenge group(≤74 points):3.45%,RHCP-S probable group(74-110 points):29.63%,RHCP-S dominant group(≥110 points):80.95%(P<0.001).CONCLUSION The overall HBsAg clearance rate with Peg-IFNα-2b retreatment was 20.74%(28/135).The RHCP-S model identifies optimal retreatment candidates(≥110 points)with 80.95%clearance probability,associated with the absence of combination NA therapy during initial treatment,greater initial HBsAg decline,longer intervals,and lower retreatment HBsAg.
基金Supported by the National Natural Science Foundation of China,No.81973840the Sichuan Provincial Administration of Traditional Chinese Medicine Major Science and Technology projects,No.2021XYCZ004。
摘要BACKGROUND Hepatocellular carcinoma(HCC)ranks as the fourth leading cause of cancerrelated deaths in China,and the treatment options are limited.The cyclic guanosine monophosphate-adenosine monophosphate synthase(cGAS)activates the stimulator of interferon gene(STING)signaling pathway as a crucial immune response pathway in the cytoplasm,which detects cytoplasmic DNA to regulate innate and adaptive immune responses.As a potential therapeutic target,cGASSTING pathway markedly inhibits tumor cell proliferation and metastasis,with its activation being particularly relevant in HCC.However,prolonged pathway activation may lead to an immunosuppressive tumor microenvironment,which fostering the invasion or metastasis of liver tumor cells.AIM To investigate the dual-regulation mechanism of cGAS-STING in HCC.METHODS This review was conducted according to the PRISMA guidelines.The study conducted a comprehensive search for articles related to HCC on PubMed and Web of Science databases.Through rigorous screening and meticulous analysis of the retrieved literature,the research aimed to summarize and elucidate the impact of the cGAS-STING pathway on HCC tumors.RESULTS All authors collaboratively selected studies for inclusion,extracted data,and the initial search of online databases yielded 1445 studies.After removing duplicates,remaining 964 records were screened.Ultimately,55 articles met the inclusion criteria and were included in this review.CONCLUSION Acute inflammation can have a few inhibitory effects on cancer,while chronic inflammation generally promotes its progression.Extended cGAS-STING pathway activation will result in a suppressive tumor microenvironment.
基金partially supported by a grant(RF1AG059694)from the U.S.National Institutes of Healthby Polytrauma System of Care,VAPAHCS(to JL)。
摘要The cyclic GMP-AMP synthase(cGAS)-stimulator of interferon genes(STING)signaling pathway has emerged as a key mediator of neuroinflammation.While current studies primarily attribute its effects to neurons and glial cells,emerging research suggests that cGAS-STING signaling may play a critical role in cerebral vasculature,particularly in brain endothelial cells.Therefore,studying the role 7of inflammation caused by the cGAS-STING pathway in brain endothelial cells could provide a more comprehensive understanding of neuroinflammatory disease and new avenues for therapeutic interventions.Here,we review the multifaceted role of global cGAS-STING signaling in various neurological and neuroinflammatory diseases and the potential contribution of cGAS-STING in brain endothelial cells.
基金Supported by National Natural Science Foundation of China(No.82471046)the Joint Medical Research Project of Chongqing Health Commission and Science and Technology Bureau(No.2023GDRC004)the Program for Youth Innovation in Future Medicine of Chongqing Medical University(No.W0185).
摘要AIM:To investigate the expression of interferon regulatory factors(IRFs)in peripheral blood mononuclear cells(PBMCs)of patients with Sjögren’s syndrome-related dry eye(SSDE)and to explore their correlation with clinical features,dendritic cell activation,and serological indicators.METHODS:A total of 53 SSDE patients and 62 non-Sjögren’s syndrome dry eye(NSSDE)patients were enrolled.Demographic and clinical data were collected,and comprehensive ophthalmic examinations were performed,including the ocular surface disease index(OSDI)questionnaires,Schirmer I test(SIT),tear break-up time(TBUT),corneal fluorescein staining score(CFS),and in vivo confocal microscopy(IVCM).PBMCs were isolated,and IRFs expression levels were analyzed using Western blotting(WB)and quantitative real-time polymerase chain reaction(qRT-PCR).Serological indicators,including antinuclear antibodies(ANA)and anti-Ro60,anti-Ro52,and anti-La autoantibodies,were detected.Statistical analyses evaluated correlations between IRFs expression and clinical parameters.RESULTS:Compared to NSSDE,the relative mRNA and protein expression of the IRF-8 was significantly upregulated in patients with SSDE(P<0.001),whereas no significant differences were observed in IRF-1,IRF-3,IRF-5,and IRF-7(P=0.12,P=0.10,P=0.66,P=0.96).Correlation analysis revealed that IRF-8 expression was positively associated with CFS and OSDI scores(r=0.57,r=0.38,both P<0.05).Moreover,IRF-8 expression correlated with corneal dendritic cell(DC)density and size,and the number of dendrites(r=0.43,r=0.40,r=0.65,all P<0.05).IRF-8 expression was significantly elevated in patients positive for anti-Ro60,anti-Ro52 and anti-La autoantibodies(P<0.05).CONCLUSION:In SSDE,IRF-8 is upregulated and associated with clinical features,DC activation,and serological indicators.These findings suggest that IRF-8 plays a critical role in SSDE pathogenesis and may serve as a potential therapeutic target for diagnosis and treatment.
基金Supported by the National Science Foundation for Distinguished Young Scholars of China to Intestinal Microflora-Mediated Regulation of Breast Regression Protein 39/chitinase-3-like Protein 1 Signaling pathway in the Intervention of Chronic Obstructive Pulmonary Disease by Invigorating Spleen Supplementing Lung and Relaxing Collaterals Method (No. 81804074)
摘要OBJECTIVE:To examine the effects of the Jianpi Yifei Tongluo recipe(健脾益肺通络方剂,JYTR)on chronic obstructive pulmonary disease(COPD)within an animal model and to elucidate its anti-inflammatory mechanisms.METHODS:In this study,we utilized cigarette smoke(CS)exposure and lipopolysaccharide(LPS)-induced models of COPD in rats to evaluate the effects of the JYTR on airway inflammation.Sprague-Dawley rats were randomly assigned to various groups:control,model,budesonide,synbiotics,and low,medium,and high JYTR.Pulmonary function was gauged using an animal volumetric tracer.Pathological alterations in lung tissue were examined under a light microscope.To ascertain cytokine production,we conducted enzyme-linked immunosorbent assay tests,and we employed Western blotting to measure the expression levels of interferon regulatory factor 4(IRF4),arginase 1(Arg1),inducible nitric oxide synthase(iNOS),nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor,alpha(IKB-α),and P65.RESULTS:Compared to the control group,rats in the COPD model group exhibited significantly compromised pulmonary function and severe inflammatory pathology in the lungs.Treatment with budesonide,synbiotics,and the JYTR markedly improved pulmonary function and diminished the production of inflammatory cytokines transforming growth factor-beta(TGF-β),tumor necrosis factor-alpha(TNF-α),and interleukin-6(IL-6).These improvements were particularly notable in the budesonide group and the high-dose JYTR group.Additionally,the JYTR increased the expression of IRF4 and upregulated the protein expression of Arg1,while concurrently downregulating the protein expression of iNOS,phosphorylated IKB-α,and phosphorylated P65.CONCLUSION:Our current study reveals that JYTR can mitigate inflammatory lung injury,enhance lung function,and lower levels of inflammatory cytokines induced by CS or LPS exposure in COPD model rats.The mechanism behind its anti-inflammatory effect likely involves the regulation of IRF4 expression and M2 polarization through the nuclear factor kappa-light-chain-enhancer of activated B cells signaling pathway.
基金Supported by Colegio de Ciencia y Tecnología de la Universidad Autónoma de la Ciudad de México,No.CCYT-2025-CON-11.
摘要The canonical signaling of interferon gamma(IFN-γ)through the Janus kinase 1 and 2–signal transducer and activator of transcription 1(STAT1)axis leads to the expression of several interferon-stimulated genes(ISGs),which have diverse effects depending on the cellular context.In glioblastoma,a highly aggressive primary brain tumor in adults,elements of IFN-γcanonical signaling are deregulated,resulting in the overexpression of STAT1-target ISGs associated with tumor progression.This mini-review highlights key ISGs,including STAT1,interferon regulatory factor 1,programmed death-ligand 1,indoleamine 2,3-dioxygenase 1,and interferon-stimulated gene 15,involved in the pathology of glioblastoma.These genes may serve as valuable biomarkers and have therapeutic potential for targeting IFN-γsignaling in this malignancy.
基金supported by the National Key Research and Development Program of China(2021YFF1200800,2018YFA0108700)the National Natural Science Foundation of China(82171861,82170256,82101448)+3 种基金Guangdong Provincial Special Support Program for Prominent Talents(2021JC06Y656)Science and Technology Planning Project of Guangdong Province(2020B1111170011,2022B1212010010)Guangzhou Science and Technology Plan Project(202201000006)the Natural Science Foundation of Sichuan Province(24NSFSC3547).
摘要The reconstruction of neural function and recovery of chronic damage following traumatic brain injury(TBI)remain significant clinical challenges.Exosomes derived from neural stem cells(NSCs)offer various benefits inTBI treatment.Numerous studies confirmed that appropriate preconditioning methods enhanced the targetedefficacy of exosome therapy.Interferon-gamma(IFN-γ)possesses immunomodulatory capabilities and is widelyinvolved in neurological disorders.In this study,IFN-γwas employed for preconditioning NSCs to enhance theefficacy of exosome(IFN-Exo,IE)for TBI.miRNA sequencing revealed the potential of IFN-Exo in promotingneural differentiation and modulating inflammatory responses.Through low-temperature 3D printing,IFN-Exowas combined with collagen/chitosan(3D-CC-IE)to preserve the biological activity of the exosome.The deliveryof exosomes via biomaterial scaffolds benefited the retention and therapeutic potential of exosomes,ensuring that they could exert long-term effects at the injury site.The 3D-CC-IE scaffold exhibited excellentbiocompatibility and mechanical properties.Subsequently,3D-CC-IE scaffold significantly improved impairedmotor and cognitive functions after TBI in rat.Histological results showed that 3D-CC-IE scaffold markedlyfacilitated the reconstruction of damaged neural tissue and promoted endogenous neurogenesis.Furthermechanistic validation suggested that IFN-Exo alleviated neuroinflammation by modulating the MAPK/mTORsignaling pathway.In summary,the results of this study indicated that 3D-CC-IE scaffold engaged in long-termpathophysiological processes,fostering neural function recovery after TBI,offering a promising regenerativetherapy avenue.
基金supported by the National Natural Science Foundation of China(Grant Nos.:82160835 and 82460866)the Natural Science Foundation of Guangxi Zhuang Autonomous Region,China(Grant No.:2023GXNSFDA026038)+2 种基金the Science and Technology Program of Liuzhou City,China(Grant Nos.:2023YRZ0101 and 2022SB001)the Scientific Research Project of Liuzhou People’s Hospital Affiliated to Guangxi Medical University,China(Grant Nos.:lry202327,lry202302,lry202403,and lry202404)the Middle-aged and Young Teachers'Basic Ability Promotion Project of Guangxi,China(Grant No.:2022KY0084)。
摘要Scutellariae Radix(SR)is widely used in Chinese medicine for influenza treatment;however,the mechanisms underlying its effect remain unknown.Here,we report,for the first time,that the therapeutic effects of SR on influenza involve regulation of antiviral interferons(IFNs),typeⅠand typeⅢIFNs(IFN-Is and IFN-Ⅲs,respectively),particularly through the modulation of IFN-I production and its downstream effects in a cell type-specific manner.SR treatment resulted in symptomatic improvement in A/Puerto Rico/8/34(H1N1)virus(PR8)-infected mice.It exhibited direct antiviral activity in the early stages of virus infection in A/WSN/33(H1N1)(WSN)-infected Madin-Darby canine kidney(MDCK)cells.Next,we investigated the effects of SR on the upstream antiviral IFN pathways and downstream effects in human lung adenocarcinoma(A549)cells,human monocytic leukemia(THP-1)cells,and neutrophils(Neu).SR exhibited dual regulatory roles,enhancing the production and activity of antiviral IFNs via the nuclear factor-kappaB(NF-κB)/IFN regulatory factor 3(IRF3)and Janus kinase/signal transducer and activator of transcription(JAK/STAT)signaling pathways.It also reduced IFN-I-induced neutrophil inflammation by inhibiting reactive oxygen species(ROS)and neutrophil extracellular trap(NET)production,and alleviated inflammation in A549 and THP-1 cells via NF-κB/cFOS or mitogen-activated protein kinase(MAPK)/c-Jun signaling.Subsequently,the importance of IFN-Ⅰ/IFN-Ⅲwas verified using IFN alpha receptor 1(Ifnar1)-/-and IFN lambda receptor 1(Ifnlr1)-/-mice.The absence of IFNAR or IFNLR significantly diminished the therapeutic effect of SR against influenza,highlighting its dependence on the IFN-Ⅰ/IFN-Ⅲsystems.Finally,a delayed drug administration experiment in PR8-infected mice revealed that the therapeutic effect of SR heavily relies on early induction of IFN.Overall,our findings offer valuable insights for the clinical utilization of SR,as well as for further exploration of antiviral treatments.
基金supported by the National Natural Science Foundation of China(Grant No.82220108002 to F.C.and Grant No.82273737 to R.Z.)the U.S.National Institutes of Health(Grant Nos.CA209414,HL060710,and ES000002 to D.C.C.,Grant Nos.CA209414 and CA249096 to Y.L.)+1 种基金the Priority Academic Program Development of Jiangsu Higher Education Institutions(PAPD)supported by the Qing Lan Project of the Higher Education Institutions of Jiangsu Province and the Outstanding Young Level Academic Leadership Training Program of Nanjing Medical University.
摘要Interferon-related genes are involved in antiviral responses,inflammation,and immunity,which are closely related to sepsis-associated acute respiratory distress syndrome(ARDS).We analyzed 1972 participants with genotype data and 681 participants with gene expression data from the Molecular Epidemiology of ARDS(MEARDS),the Molecular Epidemiology of Sepsis in the ICU(MESSI),and the Molecular Diagnosis and Risk Stratification of Sepsis(MARS)cohorts in a three-step study focusing on sepsis-associated ARDS and sepsis-only controls.First,we identified and validated interferon-related genes associated with sepsis-associated ARDS risk using genetically regulated gene expression(GReX).Second,we examined the association of the confirmed gene(interferon regulatory factor 1,IRF1)with ARDS risk and survival and conducted a mediation analysis.Through discovery and validation,we found that the GReX of IRF1 was associated with ARDS risk(odds ratio[ORMEARDS]=0.84,P=0.008;ORMESSI=0.83,P=0.034).Furthermore,individual-level measured IRF1 expression was associated with reduced ARDS risk(OR=0.58,P=8.67×10-4),and improved overall survival in ARDS patients(hazard ratio[HR28-day]=0.49,P=0.009)and sepsis patients(HR28-day=0.76,P=0.008).Mediation analysis revealed that IRF1 may enhance immune function by regulating the major histocompatibility complex,including HLA-F,which mediated more than 70%of protective effects of IRF1 on ARDS.The findings were validated by in vitro biological experiments including time-series infection dynamics,overexpression,knockout,and chromatin immunoprecipitation sequencing.Early prophylactic interventions to activate IRF1 in sepsis patients,thereby regulating HLA-F,may reduce the risk of ARDS and mortality,especially in severely ill patients.
基金financially supported by the National Natural Science Foundation of China(Grants 82404567 and 22275096)the Basic Research Program of Jiangsu Province(Grant BK20240648)Jiangsu Province Young Science and Technology Talent Support Project(Grant JSTJ‐2025‐130).
摘要1|From STING Promise to Translational Challenges The cyclic GMP‐AMP synthase‐stimulator of interferon genes(cGAS‐STING)pathway has emerged as a central innate immune‐sensing axis and a promising target for cancer immunotherapy[1-3].Upon sensing cytosolic DNA derived from pathogens,damaged cells,or tumor cells,cGAS catalyzes the production of cyclic dinucleotides(CDNs),which subsequently bind to STING and activate downstream IRF3 and NF‐κB signaling pathways[1,2].This process induces type I interferons and proinflammatory cytokines,thereby linking innate immune activation with adaptive antitumor immunity[3,4].The ability of STING signaling to activate dendritic cells,promote antigen presentation,and stimulate cytotoxic T‐cell responses has made STING agonists attractive candidates for cancer therapy[4,5].Nevertheless,clinical translation has remained difficult.CDN‐based STING agonists usually suffer from rapid enzymatic degradation,poor membrane permeability,short circulation half‐lives,and inefficient tumor accumulation after systemic administration.As a result,many early‐generation STING agonists have relied on intratumoral injection,restricting their use to accessible lesions and limiting their impact on metastatic disease[6].